Managers

Cannabis Growth Fund I looks to raise $45 mln

Cannabis Growth Fund I has changed its name from dba Kush Fund and is aiming to raise $45 million, according to a regulatory filing. The fund is managed by Gabriel Patterson and is based in Toronto, Ontario. No investors are listed.

Revolution raises $150 mln Rise of the Rest seed fund with high-profile backers

Revolution Ventures raised a $150 million Rise of the Rest seed fund with three dozen high-profile entrepreneurs and investors backing the effort, according to a press release.

U of Penn-focused Red & Blue Ventures collects $13.9 mln for maiden fund

Red & Blue Ventures has raised $13.9 million for its inaugural fund, according to an SEC filing. The target is $20 million. Based in Philadelphia, the seed and early-stage venture firm invests in companies founded by University of Pennsylvania students, faculty members and alumni.

VirtualHealth nets $7 mln in Edison Partners-led round

New York City-based VirtualHealth, a provider of population health and care management technologies, has secured $7 million in funding. Edison Partners led the round.

SQZ Biotech pulls in funding

Massachusetts-based SQZ Biotech, a preclinical stage biotechnology company, has raised an undisclosed amount of funding. The investor was JDRF T1D Fund.

VC surges into retail tech to help stores face down Amazon

Astral Capital raises $48.9 mln venture fund

Astral Capital has raised a $48.9 million venture fund, according to a filing with the SEC.

Israeli bio-pharmceutical startup ChemomAb snags $10 mln

ChemomAb, an Israeli bio-pharmaceutical start-up, has closed $10 million in funding. OrbiMed Israel and Peter Thiel led the round with participation from SBI Japan-Israel Innovation Fund and Milestone Venture.

VC-backed Outpost Medicine hires chief medical officer

Indianapolis and London-based Outpost Medicine, a biopharmaceutical company focused on treating urologic and gastrointestinal disorders, has named Dr. Ian Mills as chief medical officer. Previously, Mills worked at Mitsubishi Tanabe Pharma Europe where he was head of clinical development. Outpost Medicine is backed by Frazier Healthcare Partners, Adams Street Partners, Novo Holdings A/S, Vivo Capital and Takeda Ventures.

Norwest exits iCardiac

Norwest sold iCardiac Technologies, a provider of centralized cardiac safety and respiratory solutions. The buyer is ERT. No financial terms were disclosed.